You've successfully subscribed to Hounder Media
Great! Next, complete checkout for full access to Hounder Media
Welcome back! You've successfully signed in.
Success! Your account is fully activated, you now have access to all content.
Success! Your billing info is updated.
Billing info update failed.

GeoVax Swing Idea

A closer look at GeoVax, a clinical-stage biotech company.

Lucifer Morningstar

GeoVax Labs, Inc. (Nasdaq-CM: GOVX, GOVXW) is a clinical-stage biotechnology company with a robust pipeline of human vaccines and immunotherapies to address unmet medical needs in cancer and infectious disease.

Our products are based upon a novel patented Modified Vaccinia Ankara-Virus Like Particle (MVA-VLP) based vaccine platform. On this platform, MVA, a large virus capable of carrying several vaccine antigens, expresses proteins that assemble into VLP immunogens within (in vivo) the person receiving the vaccine.

As I sit here, eating my butter sandwich (thanks $ONTX) I wonder why in the hell would I put myself through such pain again? Ah, it's because it's part of the game.

On September 29th, they closed the offering of 2,560,000 units of its common stock, about $12.8m at $5 a share. The president, David Dodd bought $409,350 of shares priced at $5. It now down 37% since then. Do you honestly think he'd buy that many shares for a loss?

  • Unusually high volume in October.What gives? The chart looks smoother than the brains of Hindenburg Research. Should the price remain stagnant during massive buying volume? I don't think so. That tells me something a little suspicious is going on, but I'll roll with it. They have a pipeline of products coming into Q4, and they are also focusing their efforts into the COVID theme.
Pipeline for GeoVax. They can milk the COVID hype.

Link to their COVID efforts initiated in January can be found here:

They also talk about focusing efforts on curing HIV/AIDS. I should take a long position to help my fantasy football team.

**Not a financial advisor. Articles are opinions only